PGNY vs CLOV
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
PGNY
CLOV
Investment Advisor Scores
CLOV
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PGNY | CLOV | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 11.8483 | 37.7358 | PGNY |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 5.3% | 55.6% | CLOV |
| Earnings Growth | 78.9% | 0.0% | PGNY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 43.6/100 | 44.5/100 | CLOV |
| Profit Margin | 6.0% | -0.7% | PGNY |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PGNY
NeutralMixed signals - no dominant trend phase, RSI 63
CLOV
MarkupPrice above SMA50, rising 50-day trend (1.2% over 20 days), RSI 50
Fundamentals Snapshot
| Metric | PGNY | CLOV |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.5 | 30.7 |
| Trailing P/E | 31.0 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.6% |
| Gross Margin | 0.2% | 0.2% |
| Operating Margin | 0.1% | 0.0% |
| EPS | 0.94 | -0.05 |
| Dividend Yield | — | — |